Injective (INJ) is currently trading at $2.99, showing a slight decline of 0.77% over the past 24 hours. The daily price range has been tight, with a high of $3.02 and a low of $2.90, indicating limited volatility in the short term.

Volume has been robust at approximately 41.42 million, contributing to a volume-to-market cap ratio of 13.86%, suggesting a relatively active trading environment. However, the negative 7-day price change of approximately -4.82% and a 14-day decline of nearly 10% indicate ongoing bearish pressure in the medium term.

From a technical perspective, the hourly moving averages show a bullish inclination with the 8 SMA at $2.93 reflecting a 2.10% increase. The 1-hour RSI is positioned at 65, suggesting a potential overbought scenario, while the 7-day RSI at 49 indicates a neutral momentum, reflecting mixed signals.

Injective's recent price performance is far from its all-time high of $52.62, achieved on March 14, 2024, highlighting significant retracement and a need for recovery. The consistent decline over the past month, with a 30-day price change of around -5.14%, emphasizes the necessity for cautious trading approaches.

Given the current price action, technical indicators, and historical performance, a Hold rating is recommended. While short-term trading signals are bullish, the prevailing bearish trend and the risk of further declines suggest that investors should maintain their positions and await clearer bullish indicators before making additional investments.